AbsorbMax 2
AbsorbMax 2, licence 80042723: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Bio Trust Nutrition LLC.
- NPN or DIN-HM
- 80042723
- Status
- Active licence
- Licence date
- 7 June 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Dipeptidyl aminopeptidase IV Source : Aspergillus flavus var. oryzae - Cellule entière | 7.46 mg | Not calculated |
| Dipeptidyl aminopeptidase IV Source : Aspergillus flavus var. oryzae - Cellule entière | 2050.0 FCC HUT | Not calculated |
| Zingiber officinale Source : Rhizome | 25.0 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 5000.0 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 33.33 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 150.0 FCC GalU | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 5.0 mg | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger - En entier | 2500.0 FCC HCU | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger - En entier | 1.11 mg | Not calculated |
| mono ester phosphorique phosphohydrolase Source : Aspergillus niger - En entier | 1.56 mg | Not calculated |
| mono ester phosphorique phosphohydrolase Source : Aspergillus niger - En entier | 5.0 FCC FTU | Not calculated |
Non-medicinal ingredients
Eau, Gomme de gellane, Hypromellose, Carbonate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Cayenne is traditionally used in Herbal Medicine to aid digestion. Digestive enzymes. Alpha-galactosidase helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Protease helps digest proteins. Protease is a digestive aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80042723
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.